Fabrication and evaluation of poloxamer-facilitated, glyceryl monooleate-based tizanidine cubosomes

Authors

  • Milad Jawad Hasan
  • Nawal Ayash Rajab

DOI:

https://doi.org/10.60988/p.v37i2S.203

Keywords:

cubosomes; muscular spasm; tizanidine; transdermal delivery; vesicular system

Abstract

Cubosomes are lipid-based, nanostructured aqueous dispersions formed through a highly organized, spontaneous self-assembly process. These dosage forms have demonstrated potential as effective drug carriers, enhancing therapeutic efficacy. In this study, cubosomes were developed in order to evaluate their suitability as nanocarriers for the transdermal delivery of tizanidine (TZN); a skeletal muscle relaxant with low oral bioavailability. Cubosomal vesicles were prepared through the thin-film hydration technique, by using glyceryl monooleate (GMO) as the lipid component and poloxamer 407 (P407) as the stabilizer. Vesicle properties were modulated by varying the surfactant-to-lipid ratio. The developed TZN-loaded cubosomes were characterized for vesicle size (113.5–182.6 nm), polydispersity index (0.049–0.301), and drug entrapment efficiency (41.39%–79.20%). The results indicate that TZN-loaded cubosomal dispersions may represent a promising approach to transdermal drug delivery.

Author Biographies

Milad Jawad Hasan

National Center for Drugs Control & Research, Ministry of Health, Baghdad, Iraq

Nawal Ayash Rajab

Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq

References

1. Hasan M.J., Rajab N.A. Nano vesicular topical drug delivery system: types, structural components, preparation techniques, and characterizations. J. Emerg. Med. Trauma Acute Care 2024(6), 16, 2024.‏ DOI: 10.5339/jemtac.2024.absc.16

2. Fadhel A.Y., Rajab N.A. Tizanidine nano emulsion: formulation and in vitro characterization. J. Pharm. Negat. Results 13(3), 572–581, 2022. DOI: 10.47750/pnr.2022.13.03.086

3. Fadhel A.Y., Rajab N.A. Tizanidine intranasal nanoemulsion in situ gel: formulation and in vivo brain study. J. Pharm. Negat. Results 13(3), 582–591, 2022. DOI: 10.47750/pnr.2022.13.03.087

4. Noor A.H., Ghareeb M.M. Formulation and evaluation of ondansetron HCl nanoparticles for transdermal delivery. Iraqi J. Pharm. Sci. 29(2), 70–79, 2020. DOI: 10.31351/vol29iss2pp70-79

5. Al-Zheery W.H., Kassab H.J. Pharmacokinetic study of oral disulfiram suspension and topical transdermal nano-invasomes gel in Wistar rats. Al-Rafidain J. Med. Sci. 7(1), 159–163, 2024. DOI: 10.54133/ajms.v7i1.1130

6. Zaker H., Taymouri S., Mostafavi A. Formulation and physicochemical characterization of azithromycin-loaded cubosomes. Res. Pharm. Sci. 18(1), 49–58, 2022. DOI: 10.4103/1735-5362.363595

7. Alkufi H.K., Kassab H.J. Soluplus-stabilized nimodipine-entrapped spanlastic formulations prepared with edge activator (Tween20): comparative physicochemical evaluation. Pharm. Nanotechnol. 13(3), 551–563, 2025. DOI: 10.2174/0122117385348551241028102256

8. Albassam N.Y., Kassab H.J. Diacerein loaded novasome for transdermal delivery: prepartion, in vitro characterization and factors affecting formulation. Iraqi J. Pharm. Sci. 32(s), 214–224, 2023. DOI: 10.31351/vol32issSuppl.pp214-224

9. Alkawak R.S.Y., Rajab N.A. Lornoxicam-loaded cubosomes: preparation and in vitro characterization. Iraqi J. Pharm. Sci. 31(1), 144–153, 2022. DOI: 10.31351/vol31iss1pp144-153

10. Amanat S., Taymouri S., Varshosaz J., Minaiyan M., Talebi A. Carboxymethyl cellulose-based wafer enriched with resveratrol-loaded nanoparticles for enhanced wound healing. Drug Deliv. Transl. Res. 10(5), 1241–1254, 2020. DOI: 10.1007/s13346-020-00711-w

Downloads

Published

10-10-2025

How to Cite

[1]
Hasan, M.J. and Rajab, N.A. 2025. Fabrication and evaluation of poloxamer-facilitated, glyceryl monooleate-based tizanidine cubosomes. Pharmakeftiki . 37, 2S (Oct. 2025). DOI:https://doi.org/10.60988/p.v37i2S.203.